PL2178500T3 - Lek w postaci suchego proszku - Google Patents

Lek w postaci suchego proszku

Info

Publication number
PL2178500T3
PL2178500T3 PL08775998.1T PL08775998T PL2178500T3 PL 2178500 T3 PL2178500 T3 PL 2178500T3 PL 08775998 T PL08775998 T PL 08775998T PL 2178500 T3 PL2178500 T3 PL 2178500T3
Authority
PL
Poland
Prior art keywords
dry
powder medicament
medicament
powder
Prior art date
Application number
PL08775998.1T
Other languages
English (en)
Inventor
Xian-Ming Zeng
Gary Peter Martin
Christopher Marriott
Mohammed Taki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2178500T3 publication Critical patent/PL2178500T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL08775998.1T 2007-07-19 2008-07-18 Lek w postaci suchego proszku PL2178500T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0714134.4A GB0714134D0 (en) 2007-07-19 2007-07-19 Dry-powder medicament

Publications (1)

Publication Number Publication Date
PL2178500T3 true PL2178500T3 (pl) 2016-12-30

Family

ID=38476653

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08775998.1T PL2178500T3 (pl) 2007-07-19 2008-07-18 Lek w postaci suchego proszku

Country Status (15)

Country Link
US (1) US20100236550A1 (pl)
EP (2) EP3040066A1 (pl)
JP (1) JP5404618B2 (pl)
KR (2) KR101794467B1 (pl)
CN (1) CN101754746B (pl)
BR (1) BRPI0814079A2 (pl)
CA (1) CA2693577C (pl)
DK (1) DK2178500T3 (pl)
EA (1) EA025887B1 (pl)
ES (1) ES2581358T3 (pl)
GB (1) GB0714134D0 (pl)
HU (1) HUE029685T2 (pl)
IL (2) IL203379A (pl)
PL (1) PL2178500T3 (pl)
WO (1) WO2009010770A2 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
EP2221048A1 (en) * 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
JP2012524817A (ja) * 2009-04-24 2012-10-18 シェーリング コーポレイション 標的粒子サイズを有する、活性医薬を含む凝集体配合物
GB0910537D0 (en) 2009-06-18 2009-07-29 Ivax Pharmaceuticals Ireland Inhaler
TR200909791A2 (tr) * 2009-12-25 2011-07-21 B�Lg�� Mahmut Salmeterol ve flutikazon içeren farmasötik bileşim@
KR101886987B1 (ko) * 2010-09-30 2018-08-08 키에시 파르마슈티시 엣스. 피. 에이. 흡입용 건조 분말 제제 내 마그네슘 스테아레이트의 용도
JP2015155379A (ja) * 2012-05-23 2015-08-27 杏林製薬株式会社 吸入粉末剤及びその製造方法
JP5087182B1 (ja) 2012-06-13 2012-11-28 クリニプロ株式会社 吸入用パウダーの製造方法
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US9855276B2 (en) 2012-10-25 2018-01-02 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
CN103110584A (zh) * 2013-01-29 2013-05-22 青岛大学 一种噻托溴铵粉雾剂及其制备方法
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
CN105377037A (zh) * 2013-05-23 2016-03-02 Az治疗公司 用于递送色甘酸的方法
US20160129207A1 (en) * 2013-06-17 2016-05-12 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation composition filling method
AU2014340182B2 (en) 2013-10-22 2019-05-23 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
UA118861C2 (uk) * 2013-12-06 2019-03-25 Оріон Корпорейшн Спосіб отримання сухих порошкових композицій для інгаляцій
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN109922800B (zh) 2016-08-31 2023-06-13 通用医疗公司 与神经退行性疾病相关的神经炎症中的巨噬细胞/小胶质细胞
CN110603034A (zh) * 2017-05-04 2019-12-20 纳诺洛吉卡股份公司 一种适于肺、鼻、舌下和/或咽递送的,负载有至少一种生物活性化合物的多孔二氧化硅粒子的制造方法
MX2020000577A (es) 2017-07-20 2020-09-10 Aztherapies Inc Formulaciones en polvo de cromolina sodica e ibuprofeno.
JP2021529771A (ja) 2018-07-02 2021-11-04 ザ ジェネラル ホスピタル コーポレイション クロモリンナトリウムおよびα−ラクトースの粉末製剤
SG11202106117SA (en) 2018-12-10 2021-07-29 Massachusetts Gen Hospital Cromolyn esters and uses thereof
CA3125779A1 (en) * 2019-01-07 2020-07-16 Fritz Schmitt Process for producing a gaseous active ingredient or a gaseous active ingredient mixture, kit for use therein and gaseous composition
WO2021207060A1 (en) 2020-04-06 2021-10-14 The General Hospital Corporation Methods of treatment of coronavirus-induced inflammation conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
IT1309592B1 (it) * 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
JP2004500424A (ja) * 2000-04-17 2004-01-08 ヴェクトゥラ リミテッド 吸入器で使用するための製剤
GB0030074D0 (en) 2000-12-08 2001-01-24 Univ London Pharmacy Particulate inhalation carrier
DE122011100043I1 (de) * 2000-12-27 2011-12-15 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen.
AU2002333644A1 (en) * 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
US6786105B1 (en) * 2001-10-09 2004-09-07 University Of Southern California Personal particle monitor
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
AU2003269989B8 (en) * 2002-08-21 2009-11-12 Norton Healthcare Ltd. Inhalation composition

Also Published As

Publication number Publication date
WO2009010770A2 (en) 2009-01-22
US20100236550A1 (en) 2010-09-23
DK2178500T3 (en) 2016-08-01
JP5404618B2 (ja) 2014-02-05
KR20160060166A (ko) 2016-05-27
GB0714134D0 (en) 2007-08-29
EP2178500A2 (en) 2010-04-28
CN101754746B (zh) 2015-08-19
HK1141448A1 (zh) 2010-11-12
BRPI0814079A2 (pt) 2015-02-03
EA201070162A1 (ru) 2010-06-30
ES2581358T3 (es) 2016-09-05
EP2178500B1 (en) 2016-05-04
IL246189B (en) 2019-08-29
CA2693577C (en) 2015-06-23
KR101794467B1 (ko) 2017-12-01
KR20100049072A (ko) 2010-05-11
HUE029685T2 (en) 2017-03-28
EA025887B1 (ru) 2017-02-28
WO2009010770A3 (en) 2010-01-07
CN101754746A (zh) 2010-06-23
IL246189A0 (en) 2016-07-31
EP3040066A1 (en) 2016-07-06
IL203379A (en) 2016-06-30
CA2693577A1 (en) 2009-01-22
JP2010533697A (ja) 2010-10-28

Similar Documents

Publication Publication Date Title
IL246189A0 (en) Medicine in dry powder form
IL200565A0 (en) Inhaler
ZA200909172B (en) Inhaler
IL236360A0 (en) Inhalable medicine
ZA201001435B (en) Inhaler
IL195247A0 (en) Inhaler
HUE038232T2 (hu) Inhalátor
PL2203205T3 (pl) Inhalator
AU321242S (en) Inhaler
IL175664A0 (en) Dry-powder inhaler
GB0721332D0 (en) Medicaments
GB2434754B (en) Inhaler
GB0803054D0 (en) Medicament
EP2310022A4 (en) TOPIC MEDICINE
GB0625783D0 (en) Medicament
AU316472S (en) Cannula
GB0717450D0 (en) Medicament
AP2006000208S (en) Inhaler
GB0613031D0 (en) Medicaments
GB0615064D0 (en) Medicament
GB0721333D0 (en) Medicaments
GB0711139D0 (en) New medicine use
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
TWM292546U (en) Medicament counter